Cargando…
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
Coronavirus infectious diseases 2019 (COVID-19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a serious public health threat worldwide. So far, there are no drugs and vaccines whose efficacy has been well-proven. After the outbreak, there has bee...
Autor principal: | Watashi, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678433/ https://www.ncbi.nlm.nih.gov/pubmed/33272566 http://dx.doi.org/10.1016/j.bbrc.2020.10.094 |
Ejemplares similares
-
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
por: Kutkat, Omnia, et al.
Publicado: (2022) -
Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023) -
Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023) -
Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)